Prescription Drugs

The PDMP TTAC team hosts and facilitates monthly conference calls with the RxCheck Governance Board; the PMIX Standards Organization; the PMIX Operations, Technical, Standards Compliance Subcommittees; and ad hoc committees as needed to support the groups in accomplishing their goals. During this reporting period, the PDMP TTAC team hosted and facilitated 7 conference calls with the various PMIX groups.

Fidelity Assessment interview conducted with RSAT program staff from the Rhode Island Department of Corrections, John J. Moran Medium Security Facility.

Fidelity Assessment interview conducted with RSAT program staff from the Carl Robinson Correctional Institution in Connecticut.

Fidelity Assessment interview conducted with RSAT program staff from the Osborne Correctional Institution in Connecticut.

The Bureau of Justice Assistance (BJA) and Centers for Disease Control and Prevention (CDC) leadership, in collaboration with the Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) team at the Institute for Intergovernmental Research (IIR), invite you to this no-cost Learning Community for Rural Jurisdictions occurring the second Tuesday of each month beginning February 14 from 2:00 p.m. – 3:30 p.m., ET.

Peer recovery support services (PRSS) are increasingly offered across diverse community, criminal justice, and healthcare settings to address opioid, stimulant, and other substance use disorders, as well as mental health and co-occurring disorders.

The first webinar in the series will serve as an introduction to two decades of trends in the illicit drug using fatal overdose data. Silvana Mazzella from Prevention Point Philadelphia will detail the association between these trends and drug use behaviors, especially as it pertains to the use of synthetic opioids like fentanyl, and the emerging co-use trends with stimulants and the introduction of xylazine in the region. Dr.

The first webinar in the series will serve as an introduction to two decades of trends in the illicit drug using fatal overdose data. Silvana Mazzella from Prevention Point Philadelphia will detail the association between these trends and drug use behaviors, especially as it pertains to the use of synthetic opioids like fentanyl, and the emerging co-use trends with stimulants and the introduction of xylazine in the region. Dr.

Prosecutors are in a unique position to disrupt the revolving door of persons with substance use disorders (SUDs) into and out of jails. They can create “exits” by intercepting those with SUDs and referring them to appropriate community treatment programs. Prosecutor-led diversion programs can reduce the burden on the justice system while providing high and low risk individuals with access to needed treatment and recovery supports.

Learn how the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Confidentiality of Substance Use Disorder Patient Records (42 CFR Part 2) apply to medications for opioid use disorder in correctional entities, especially jails, prisons, and detention centers. This webinar, led by national experts at the Center of Excellence for Protected Health Information, will provide an overview of federal health privacy laws and guide participants through common scenarios in which patient information may or may not be shareable.